Daily General Analysis
June 22, 2026
Quick Analysis: 5 Market-Moving Facts (06/23/2026)
Folks, I sat down with a double espresso and organized what really matters for the week. Let's get straight to what moves the portfolio.
1. Geopolitics at Play: Tension in the Strait of Hormuz
Summary: The U.S. threatens to "blow up" Iran if the Strait of Hormuz is closed, sending oil prices soaring and dragging down Dow Jones futures.
Effect: I Would Reduce exposure to cyclical and consumer discretionary sectors in the short term. Sky-high oil means inflation straight into the veins.
Affected Assets/Sectors: Oil & Gas Sector (XOM, CVX), Airlines (DAL, UAL), S&P 500 Index (SPY), Shipping Companies (ZIM)
2. SpaceX IPO: Rocket of Euphoria or Sure Profit?
Summary: SpaceX (NASDAQ: SPCX) debuted on the exchange at $135, closed at $160.95, and is already the biggest IPO story of 2026.
Effect: I Would Buy on any dip down to $150. The post-IPO valuation still doesn't reflect NASA contracts and Starlink. It's growth with rocket fuel.
Affected Assets/Sectors: SpaceX (SPCX), Satellite Manufacturing (BA), Defense ETFs (ITA), Boeing (BA)
3. TSMC Explodes, Taking Taiwan's Market to Record Highs
Summary: TSMC (NYSE: TSM) surged to NT$ 2,510 (local shares), pulling Taiwan's index (TWII) to an all-time high of 47,741 points, up +2.75% in a single day.
Effect: I Would Buy any dip in TSM and equipment suppliers. Demand for AI chips shows no signs of slowing down.
Affected Assets/Sectors: TSMC (TSM), ASML (ASML), Advanced Micro Devices (AMD), Semiconductor Sector (SOXX)
4. Grail: A Blood Test That Could Save Lives (and Your Portfolio)
Summary: Grail (NASDAQ: GRAL) advances with its early detection test for 50+ types of cancer, approaching large-scale commercial approval.
Effect: I Would Buy GRAL in the $30-35 range. If the FDA approves widespread use, revenue skyrockets. High risk, but massive potential return.
Affected Assets/Sectors: Grail (GRAL), Illumina (ILMN), Exact Sciences (EXAS), Diagnostics Sector (XLV)
5. OpenAI and Anthropic: Two Bullets in the AI IPO Chamber
Summary: OpenAI and Anthropic (already valued at $965 billion) have confidential S-1 filings and could go public by the end of the year.
Effect: I Would Hold positions in thematic AI ETFs (like BOTZ or AIQ) to capture this wave through indirect exposure.
Affected Assets/Sectors: Microsoft (MSFT), Alphabet (GOOGL), Nvidia (NVDA), AI ETFs (BOTZ, AIQ)
Immediate Opportunities
- Buy on Weakness: If oil corrects after Middle East tensions ease, buy shares of trucking and logistics companies (JBHT) that suffered from high diesel costs.
- Position in Biotech: Grail (GRAL) is the clearest medium-term bet. If the test gets approved, the move could be 5x-10x.
- Semiconductor Sector: TSM (TSM) and ASML (ASML) are the "pickaxes and shovels" of the AI gold rush. Buy on the dip.
- SpaceX IPO: If you get an allocation, hold it. If not, buy on the secondary market if it drops below $150.
Risks on the Radar
- Market Concentration: 12 U.S. companies are worth $30 trillion. Any bad news from a big tech could trigger a 15% correction in the S&P 500.
- Skyrocketing Oil: If the barrel price stays above $120 for more than a month, inflation returns and the Fed will have to raise rates.
Related News
Your Passport to Global Investments
Ivar recommends Swissquote bank for your international investments. By opening your account through the link below and trading 5 lots or more, you will receive $200 to use on Ivar AI and activate your subscription. Take advantage of this exclusive offer available today!
Offer available for you who have not yet opened your account at Swissquote.
Services available globally except for the following countries: Algeria, Belgium, Canada, China, North Korea, USA, France, Hong Kong, Iran, Iraq, Nigeria, Singapore, Syria, Turkey and Zimbabwe.
About Us
Av Norte Miguel Arraes de Alencar, 3003. CP974. Encruzilhada, Recife-PE, Brasil.
+55(81)98180-0091
support@ivar-ai.com